“Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions”, J of Skin, vol. 9, no. 6, p. s711, Nov. 2025, doi: 10.25251/36mxmk39.